PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or Metastatic

Clinical trial NCT01540253 · COMPLETED

Trial details

NCT number

NCT01540253

Sponsor

Roswell Park Cancer Institute

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2012-05-01

Primary completion

2015-06-01

Enrollment

38

View on ClinicalTrials.gov